Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print

Breaking News

Related Searches:
May 16, 2011
Quintiles and Population Genetics Technologies Ltd. (PGT) have entered a commercial collaboration to bring genomic testing into mainstream drug development in an effort to produce safer, more effective medicines.   Read More »
May 16, 2011
Elizabeth Thomas has been appointed vice president and general manager of ICON’s Bioanalytical Operations in Manchester, UK.   Read More »
May 16, 2011
Data analysis services to speed discovery programs  Read More »
May 13, 2011
Phlexglobal has expanded in the U.S. with the opening of an office in Philadelphia, PA.  Read More »
May 13, 2011
Paladin Labs has entered into a licensing and distribution agreement with Elan Corp. under which Paladin has exclusive Canadian rights to market and sell (upon regulatory approval) Elan’s controlled release hydrocodone product for the treatment of m  Read More »
May 13, 2011
Harman Dubé has been appointed vice president of the Preclinical and Regulatory Affairs group within OckhamCRO.  Read More »
May 13, 2011
North America revenue growth was 18% for the year, with 11 new product launches.   Read More »
May 12, 2011
Pre-Approval Inspection leads to commercial API launch  Read More »
May 12, 2011
Harry Jeffreys has been appointed vice president of Quality Management Systems and Compliance at Catalent Pharma Solutions.  Read More »
May 12, 2011
Oncolytics Biotech has entered into a commercial supply agreement with SAFC, a division of Sigma-Aldrich Corp., for the commercial manufacture of Oncolytics’ reovirus, Reolysin.   Read More »
May 12, 2011
Dr. Dorla Mirejovsky has been appointed senior director of Formulation Development at Irvine Pharmaceutical Services.  Read More »
May 12, 2011
SilenceSelect tech to assist CNS research  Read More »
May 12, 2011
Service revenues rise, lead to net profit  Read More »
May 11, 2011
Michael E. Lytton has been appointed Patheon’s executive vice president of Corporate Development and Strategy and general counsel.  Read More »
May 11, 2011
Halozyme Therapeutics and ViroPharma have signed a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) for the development of a subcutaneous formulation of Cinryze.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On